Treatment of pain crisis at end of life from severe lower extremity venous outflow obstruction with hyperalgesia and allodynia

Journal of Pain

Volumn 3, Issue 3, 2002, Pages 244-248

  Gordon, Debra B ^a   Sehgal, Nalini ^a   Schroeder, Mark E ^a   Cleary, James ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Bupivacaine; Cancer; Case study; Ketamine; Methadone; Subarachnoid; Venous outflow obstruction

Indexed keywords

BUPIVACAINE; FENTANYL; GABAPENTIN; HYDROMORPHONE; KETAMINE; LORAZEPAM; LOW MOLECULAR WEIGHT HEPARIN; METHADONE; MORPHINE; WARFARIN;

ADENOCARCINOMA; ADULT; ALLODYNIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; HYPERALGESIA; INFERIOR CAVA VEIN; LEG PAIN; LEG VEIN; LUNG METASTASIS; RETROPERITONEAL CANCER; SPINAL ANESTHESIA; STENT; TERMINAL DISEASE; UTERINE CERVIX CANCER; VEIN BLOOD FLOW; VEIN OCCLUSION;

EID: 0036083497     PISSN: 15265900     EISSN: None     Source Type: Journal    
DOI: 10.1054/jpai.2002.122948     Document Type: Article

References (26)

1. Vascular and stromal features in the skin of the lower limb in patients with chronic critical limb ischaemia (CLI) and oedema
2. Response of chronic neuropathic pain syndromes to ketamine: A preliminary study
3. Delayed onset muscle soreness: Effect of an ischaemic block upon mechanical allodynia in humans
4. Clinical guidelines for intraspinal infusion: Report of an expert panel
5. Evidence-based review of the literature on intrathecal delivery of pain medicine
6. Ketamine injection used orally
7. Opioid rotation in patients with cancer pain
8. Opioid pharmacotherapy in the management of cancer pain: A survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration
9. The influence of baricity on the haemodynamic effects of intrathecal bupivacaine 0.5%
10. Clinical experience with oral ketamine
11. Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain
12. Does intravenous methadone provide longer lasting analgesia than intravenous morphine? A randomized, doubleblind study
13. Intrathecal bupivacaine in humans: Influence of volume and baricity in solutions
14. Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: Clinical observations
15. Ketamine in cancer pain: An update
16. New perspectives in our use of opioids
17. A case of unilateral recurrent calf myalgia with muscle edema due to venous congestion
18. Opioid rotation for toxicity reduction in terminal cancer patients
19. Respiratory depression following administration of intrathecal bupivacaine to an opioid-dependent patient
20. NMDA-receptor antagonists and opioid receptor interactions as related to analgesia and tolerance
21. An update on the clinical use of methadone for cancer pain
22. Switching from morphine to oral methadone in treating cancer pain: What is an equianalgesic dose ratio?
23. NMDA-receptor antagonists in neuropathic pain: Experimental methods to clinical trials
24. The role of dorsal root reflexes in neurogenic inflammation
25. Spinal analgesia with hyperbaric bupivacaine effects of volume of solution
26. Facilitated neurogenic inflammation in complex regional pain syndrome